BioClinica, Inc.
826 Newtown-Yardley Road
Newtown,
PA 18940
United States - Map
Phone: 267-757-3000
Fax: 267-757-3010
Web Site: http://www.bioclinica.com
| BioClinica, Inc. operates as a global provider of clinical trials services, helping to support drug and product development efforts through various phases of the clinical trial process. BioClinica, created from the acquisition of Phoenix Data Systems, Inc. by Bio-Imaging Technologies, Inc., offers medical image management and electronic data capture to companies in the life sciences industry. The company also provides solutions that combine these core services to maximize efficiency and manageability throughout the clinical development process. In addition, BioClinica offers streamlined electronic transport solutions to facilitate the blinding, sharing, tracking, and archiving of medical images for multi-center clinical trials, as part of its suite of imaging services. BioClinica, with approximately 2,000 successful trials, helps in bringing various drugs from early phase development through final approval. It operates two FDA-compliant core labs in the United States and Europe. The company was formerly known as Bio-Imaging Technologies, Inc. and changed its name to BioClinica, Inc. on July 8, 2009. BioClinica was founded in 1987 and is based in Newtown, Pennsylvania with business offices in the United States, France, Germany, the United Kingdom, and the Netherlands. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Mark L. Weinstein , 56
Chief Exec. Officer, Pres and Exec. Director |
$
643.00K |
$
952.00K | Mr. Ted Kaminer , 50
Chief Financial Officer and Exec. VP of Fin. & Admin. |
$
431.00K |
$
27.00K | Mr. David A. Pitler , 54
Exec. VP and Pres of Bio-Imaging Services |
$
368.00K |
$
75.00K | Mr. Peter S. Benton , 44
Pres of eClinical Division and Exec. VP |
N/A
| N/A | Jim Dorsey ,
VP of Marketing |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.19% Nasdaq 
0.11 (2.68%) 
Profile
